Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: E9AIQ4
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 3 |
GO:0016491 | oxidoreductase activity | 2 | 3 |
GO:0051213 | dioxygenase activity | 3 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 348 | 352 | PF00656 | 0.578 |
CLV_NRD_NRD_1 | 206 | 208 | PF00675 | 0.426 |
CLV_NRD_NRD_1 | 321 | 323 | PF00675 | 0.526 |
CLV_PCSK_KEX2_1 | 321 | 323 | PF00082 | 0.534 |
CLV_PCSK_SKI1_1 | 134 | 138 | PF00082 | 0.353 |
CLV_PCSK_SKI1_1 | 172 | 176 | PF00082 | 0.374 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.470 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.557 |
DOC_MAPK_DCC_7 | 105 | 114 | PF00069 | 0.368 |
DOC_MAPK_DCC_7 | 337 | 347 | PF00069 | 0.378 |
DOC_MAPK_gen_1 | 169 | 178 | PF00069 | 0.337 |
DOC_MAPK_MEF2A_6 | 105 | 114 | PF00069 | 0.601 |
DOC_PP2B_LxvP_1 | 151 | 154 | PF13499 | 0.361 |
DOC_PP4_FxxP_1 | 160 | 163 | PF00568 | 0.441 |
DOC_PP4_FxxP_1 | 37 | 40 | PF00568 | 0.503 |
DOC_PP4_MxPP_1 | 188 | 191 | PF00568 | 0.258 |
DOC_USP7_MATH_1 | 100 | 104 | PF00917 | 0.381 |
DOC_USP7_MATH_1 | 177 | 181 | PF00917 | 0.437 |
DOC_USP7_MATH_1 | 256 | 260 | PF00917 | 0.348 |
DOC_WW_Pin1_4 | 181 | 186 | PF00397 | 0.341 |
DOC_WW_Pin1_4 | 231 | 236 | PF00397 | 0.461 |
LIG_14-3-3_CanoR_1 | 195 | 205 | PF00244 | 0.422 |
LIG_14-3-3_CanoR_1 | 207 | 211 | PF00244 | 0.299 |
LIG_BIR_III_4 | 311 | 315 | PF00653 | 0.332 |
LIG_EH_1 | 254 | 258 | PF12763 | 0.386 |
LIG_eIF4E_2 | 38 | 44 | PF01652 | 0.365 |
LIG_FHA_1 | 115 | 121 | PF00498 | 0.472 |
LIG_FHA_1 | 146 | 152 | PF00498 | 0.442 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.430 |
LIG_FHA_1 | 23 | 29 | PF00498 | 0.468 |
LIG_FHA_1 | 240 | 246 | PF00498 | 0.393 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.379 |
LIG_FHA_2 | 248 | 254 | PF00498 | 0.388 |
LIG_FHA_2 | 79 | 85 | PF00498 | 0.438 |
LIG_Integrin_RGD_1 | 221 | 223 | PF01839 | 0.440 |
LIG_LIR_Apic_2 | 35 | 41 | PF02991 | 0.376 |
LIG_LIR_Gen_1 | 50 | 60 | PF02991 | 0.320 |
LIG_LIR_Nem_3 | 201 | 206 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 338 | 342 | PF02991 | 0.455 |
LIG_LIR_Nem_3 | 50 | 55 | PF02991 | 0.305 |
LIG_SH2_CRK | 203 | 207 | PF00017 | 0.348 |
LIG_SH2_CRK | 38 | 42 | PF00017 | 0.377 |
LIG_SH2_SRC | 38 | 41 | PF00017 | 0.406 |
LIG_SH2_STAP1 | 273 | 277 | PF00017 | 0.277 |
LIG_SH2_STAT3 | 273 | 276 | PF00017 | 0.448 |
LIG_SH2_STAT5 | 226 | 229 | PF00017 | 0.365 |
LIG_SH2_STAT5 | 273 | 276 | PF00017 | 0.346 |
LIG_SH2_STAT5 | 52 | 55 | PF00017 | 0.300 |
LIG_SH3_3 | 151 | 157 | PF00018 | 0.476 |
LIG_SH3_3 | 26 | 32 | PF00018 | 0.407 |
LIG_SH3_3 | 96 | 102 | PF00018 | 0.411 |
LIG_SUMO_SIM_anti_2 | 171 | 177 | PF11976 | 0.335 |
LIG_SUMO_SIM_par_1 | 174 | 180 | PF11976 | 0.253 |
LIG_SUMO_SIM_par_1 | 190 | 197 | PF11976 | 0.487 |
MOD_CDK_SPxxK_3 | 231 | 238 | PF00069 | 0.461 |
MOD_CK1_1 | 125 | 131 | PF00069 | 0.391 |
MOD_CK1_1 | 196 | 202 | PF00069 | 0.386 |
MOD_CK2_1 | 257 | 263 | PF00069 | 0.364 |
MOD_CK2_1 | 328 | 334 | PF00069 | 0.398 |
MOD_CK2_1 | 78 | 84 | PF00069 | 0.409 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.388 |
MOD_GlcNHglycan | 259 | 262 | PF01048 | 0.455 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.416 |
MOD_GSK3_1 | 141 | 148 | PF00069 | 0.286 |
MOD_GSK3_1 | 177 | 184 | PF00069 | 0.237 |
MOD_GSK3_1 | 239 | 246 | PF00069 | 0.528 |
MOD_GSK3_1 | 267 | 274 | PF00069 | 0.433 |
MOD_N-GLC_1 | 141 | 146 | PF02516 | 0.322 |
MOD_N-GLC_1 | 280 | 285 | PF02516 | 0.322 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.422 |
MOD_NEK2_1 | 206 | 211 | PF00069 | 0.301 |
MOD_NEK2_1 | 257 | 262 | PF00069 | 0.358 |
MOD_NEK2_1 | 267 | 272 | PF00069 | 0.220 |
MOD_NEK2_1 | 345 | 350 | PF00069 | 0.519 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.486 |
MOD_NEK2_2 | 177 | 182 | PF00069 | 0.230 |
MOD_PIKK_1 | 196 | 202 | PF00454 | 0.285 |
MOD_PK_1 | 161 | 167 | PF00069 | 0.324 |
MOD_PKA_2 | 168 | 174 | PF00069 | 0.349 |
MOD_PKA_2 | 194 | 200 | PF00069 | 0.399 |
MOD_PKA_2 | 206 | 212 | PF00069 | 0.307 |
MOD_Plk_1 | 141 | 147 | PF00069 | 0.464 |
MOD_Plk_4 | 125 | 131 | PF00069 | 0.390 |
MOD_Plk_4 | 161 | 167 | PF00069 | 0.365 |
MOD_Plk_4 | 247 | 253 | PF00069 | 0.545 |
MOD_Plk_4 | 268 | 274 | PF00069 | 0.336 |
MOD_Plk_4 | 328 | 334 | PF00069 | 0.493 |
MOD_ProDKin_1 | 181 | 187 | PF00069 | 0.347 |
MOD_ProDKin_1 | 231 | 237 | PF00069 | 0.458 |
MOD_SUMO_for_1 | 335 | 338 | PF00179 | 0.495 |
TRG_DiLeu_BaEn_1 | 263 | 268 | PF01217 | 0.424 |
TRG_DiLeu_BaLyEn_6 | 188 | 193 | PF01217 | 0.410 |
TRG_DiLeu_LyEn_5 | 26 | 31 | PF01217 | 0.411 |
TRG_ENDOCYTIC_2 | 203 | 206 | PF00928 | 0.348 |
TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.300 |
TRG_ER_diArg_1 | 43 | 46 | PF00400 | 0.268 |
TRG_Pf-PMV_PEXEL_1 | 330 | 334 | PF00026 | 0.512 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBK0 | Leptomonas seymouri | 81% | 97% |
A0A0S4JR98 | Bodo saltans | 50% | 100% |
A0A1X0NXW7 | Trypanosomatidae | 62% | 100% |
A0A3S7WWQ0 | Leishmania donovani | 87% | 99% |
A0A422NSQ3 | Trypanosoma rangeli | 61% | 100% |
A4HZC9 | Leishmania infantum | 87% | 99% |
D0A155 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 100% |
E9AVB6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 99% |
Q4QC64 | Leishmania major | 88% | 100% |
V5BRD2 | Trypanosoma cruzi | 64% | 100% |